Glomerulonephritis News and Research

RSS
Circulating protein predicts risk of chronic kidney disease

Circulating protein predicts risk of chronic kidney disease

Stem cell biology and gene-editing techniques offer hope for kidney regeneration

Stem cell biology and gene-editing techniques offer hope for kidney regeneration

Pabetalone (RVX-208) to be tested in proof-of-concept pilot study in complement mediated diseases

Pabetalone (RVX-208) to be tested in proof-of-concept pilot study in complement mediated diseases

Avexxin concludes second phase I/IIA study in patients suffering from mild-to-moderate psoriasis

Avexxin concludes second phase I/IIA study in patients suffering from mild-to-moderate psoriasis

NEFIGAN Trial of Nefecon for treatment of primary IgA nephropathy meets primary endpoint

NEFIGAN Trial of Nefecon for treatment of primary IgA nephropathy meets primary endpoint

Asian and Hispanic patients with lupus have lower mortality rates

Asian and Hispanic patients with lupus have lower mortality rates

Anthera Pharmaceuticals to host Lupus symposium in San Francisco

Anthera Pharmaceuticals to host Lupus symposium in San Francisco

Roche announces launch of cobas Liat System for on-demand testing in different settings

Roche announces launch of cobas Liat System for on-demand testing in different settings

Alere starts voluntary correction about use of Alere INRatio and INRatio 2 PT/INR Monitor system

Alere starts voluntary correction about use of Alere INRatio and INRatio 2 PT/INR Monitor system

Researchers discover second protein associated with membranous nephropathy

Researchers discover second protein associated with membranous nephropathy

Anthera Pharmaceuticals reports net loss of $7.0 million for third quarter 2014

Anthera Pharmaceuticals reports net loss of $7.0 million for third quarter 2014

Pharmalink’s core patents for Nefecon issued in United States, Europe, China and Hong Kong

Pharmalink’s core patents for Nefecon issued in United States, Europe, China and Hong Kong

ANMAT approves Genzyme’s Lemtrada for treatment of relapsing remitting multiple sclerosis

ANMAT approves Genzyme’s Lemtrada for treatment of relapsing remitting multiple sclerosis

Health Canada approves Genzyme's Lemtrada for adults with relapsing remitting multiple sclerosis

Health Canada approves Genzyme's Lemtrada for adults with relapsing remitting multiple sclerosis

EMA's CHMP issues positive opinion for approval of Genzyme's LEMTRADA in Europe

EMA's CHMP issues positive opinion for approval of Genzyme's LEMTRADA in Europe

BH3-mimetics might be new option for treatment of autoimmune conditions

BH3-mimetics might be new option for treatment of autoimmune conditions

Study tracks movements of leukocytes through the kidney

Study tracks movements of leukocytes through the kidney

Biopsy required for accurate renal diagnosis in diabetes

Biopsy required for accurate renal diagnosis in diabetes

TGen's customized procedure produces high amounts of exosomes for treatment of CKD

TGen's customized procedure produces high amounts of exosomes for treatment of CKD

Psoriasis link with autoimmune diseases underscored

Psoriasis link with autoimmune diseases underscored